Bioxcel Therapeutics logo

Bioxcel Therapeutics Share Price Today

(NASDAQ: BTAI)

Bioxcel Therapeutics share price is $2.73 & ₹237.43 as on 6 Mar 2025, 2.30 'hrs' IST

$2.73

0.03

(1.11%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Bioxcel Therapeutics share price in Dollar and Rupees. Guide to invest in Bioxcel Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Bioxcel Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Bioxcel Therapeutics share price movements

  • Today's Low: $2.73
    Today's High: $3.28

    Day's Volatility :16.77%

  • 52 Weeks Low: $1.72
    52 Weeks High: $52.80

    52 Weeks Volatility :96.74%

Bioxcel Therapeutics (BTAI) Returns

PeriodBioxcel TherapeuticsSector (Health Care)Index (Russel 2000)
3 Months
-55.33%
3.7%
0.0%
6 Months
-71.09%
-2.8%
0.0%
1 Year
-94.24%
2.5%
0.0%
3 Years
-99.03%
12.9%
-11.6%

Bioxcel Therapeutics (BTAI) Key Statistics

in dollars & INR

Previous Close
$2.7
Open
$3.18
Today's High
$3.28
Today's Low
$2.73
Market Capitalization
$8.5M
Today's Volume
$10.1M
52 Week High
$52.8
52 Week Low
$1.72
Revenue TTM
$2.3M
EBITDA
$-73.9M
Earnings Per Share (EPS)
$-32.64
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1766.94%

How to invest in Bioxcel Therapeutics Stock (BTAI) from India?

It is very easy for Indian residents to invest directly in Bioxcel Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bioxcel Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bioxcel Therapeutics or BTAI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bioxcel Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bioxcel Therapeutics shares which would translate to 0.319 fractional shares of Bioxcel Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bioxcel Therapeutics, in just a few clicks!

Returns in Bioxcel Therapeutics (BTAI) for Indian investors in Rupees

The Bioxcel Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bioxcel Therapeutics investment value today

Current value as on today

₹10,713

Returns

₹89,287

(-89.29%)

Returns from Bioxcel Therapeutics Stock

₹94,236 (-94.24%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Bioxcel Therapeutics (BTAI)

486.27%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Bioxcel Therapeutics Shares from India has grown by 486.27% over the past 30 days, indicating increased transactional activity.

673%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Bioxcel Therapeutics Stock from India on INDmoney has increased by 673% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Bioxcel Therapeutics

  • BlackRock Inc

    0.77%

  • Geode Capital Management, LLC

    0.60%

  • Wells Fargo & Co

    0.37%

  • Renaissance Technologies Corp

    0.26%

  • Millennium Management LLC

    0.26%

  • Bank of America Corp

    0.17%

Analyst Recommendation on Bioxcel Therapeutics

Buy

    69%Buy

    30%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Bioxcel Therapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
10
Hold
4
5
4
Sell
0
0
0

Analyst Forecast on Bioxcel Therapeutics Stock (BTAI)

What analysts predicted

Upside of 1255.31%

Target:

$37.00

Current:

$2.73

Insights on Bioxcel Therapeutics Stock (Ticker Symbol: BTAI)

  • Price Movement

    In the last 7 days, BTAI stock has moved up by 57.8%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.10M → 214.0K (in $), with an average decrease of 80.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -8.29M → -13.65M (in $), with an average decrease of 64.5% per quarter
  • BTAI vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 160.7%
  • BTAI vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 150.6%
  • Price to Sales

    ForBTAI every $1 of sales, investors are willing to pay $2.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Bioxcel Therapeutics Technicals Summary

Sell

Neutral

Buy

Bioxcel Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Bioxcel Therapeutics (BTAI) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bioxcel Therapeutics logo
-40.13%
-71.09%
-94.24%
-99.03%
-99.41%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bioxcel Therapeutics logo
NA
NA
NA
-25.33
-17.67
-0.62
NA
-32.27
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bioxcel Therapeutics logo
Buy
$8.5M
-99.41%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Bioxcel Therapeutics

BioXcel Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product, IGALMI, a sublingual film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. The company also continues to conduct clinical trials evaluating BXCL501 for the acute treatment of agitation in Alzheimer's disease patients, and for adjunctive treatment of patients with major depressive disorder, as well as in the community for agitation associated with bipolar disorders and schizophrenia. In addition, it is developing BXCL502 as a potential therapy for chronic agitation in dementia; and BXCL701, an investigational, orally innate immunity activator for the treatment of aggressive forms of prostate cancer, pancreatic cancer, and other solid and liquid tumors; BXCL503, a drug candidate to target apathy in dementia; and BXCL504, a drug candidate to target aggression in dementia. BioXcel Therapeutics, Inc. was incorporated in 2017 and is headquartered in New Haven, Connecticut.
Organization
Bioxcel Therapeutics
Employees
74
CEO
Dr. Vimal D. Mehta Ph.D.
Industry
Health Technology

Management People of Bioxcel Therapeutics

NameTitle
Dr. Vimal D. Mehta Ph.D.
Founder, CEO, President, & Director
Mr. Javier Rodriguez J.D.
Senior VP, Chief Legal Officer & Corporate Secretary
Mr. Richard I. Steinhart MBA
Senior VP & CFO
Dr. Frank D. Yocca Ph.D.
Senior VP & Chief Scientific Officer
Dr. Vincent J. O'Neill B.Sc., M.D., M.R.C.P.
Executive VP and Chief of Product Development & Medical Officer

Important FAQs about investing in BTAI Stock from India :

What is Bioxcel Therapeutics share price today?

Bioxcel Therapeutics share price today stands at $2.73, Open: $3.18 ; Previous Close: $2.70 ; High: $3.28 ; Low: $2.73 ; 52 Week High: $52.80 ; 52 Week Low: $1.72.

The stock opens at $3.18, after a previous close of $2.70. The stock reached a daily high of $3.28 and a low of $2.73, with a 52-week high of $52.80 and a 52-week low of $1.72.

Can Indians buy Bioxcel Therapeutics shares?

Yes, Indians can invest in the Bioxcel Therapeutics (BTAI) from India.

With INDmoney, you can buy Bioxcel Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Bioxcel Therapeutics at zero transaction cost.

How can I buy Bioxcel Therapeutics shares from India?

It is very easy to buy Bioxcel Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bioxcel Therapeutics (BTAI) be purchased?

Yes, you can buy fractional shares of Bioxcel Therapeutics with INDmoney app.

What are the documents required to start investing in Bioxcel Therapeutics stocks?

To start investing in Bioxcel Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Bioxcel Therapeutics Stock (BTAI)?

Today’s highest price of Bioxcel Therapeutics (BTAI) is $3.28.

Today’s lowest price of Bioxcel Therapeutics (BTAI) is $2.73.

What is today's market capitalisation of Bioxcel Therapeutics?

Today's market capitalisation of Bioxcel Therapeutics BTAI is 8.5M

What is the 52 Week High and Low Range of Bioxcel Therapeutics Stock (BTAI)?

  • 52 Week High

    $52.80

  • 52 Week Low

    $1.72

What are the historical returns of Bioxcel Therapeutics (BTAI)?

  • 1 Month Returns

    -40.13%

  • 3 Months Returns

    -71.09%

  • 1 Year Returns

    -94.24%

  • 5 Years Returns

    -99.41%

Who is the Chief Executive Officer (CEO) of Bioxcel Therapeutics ?

Dr. Vimal D. Mehta Ph.D. is the current Chief Executive Officer (CEO) of Bioxcel Therapeutics.